veliparib (ABT-888) / AbbVie  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

6 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
veliparib (ABT-888) / AbbVie
NCT01837212: Veliparib and Temozolomide For Compassionate Use in Patients With Primary Refractory Ovarian Cancer

Enrolling by invitation
N/A
3
US
veliparib, ABT-888, temozolomide, SCH 52365, Temodal, Temodar, TMZ
New Mexico Cancer Care Alliance, National Cancer Institute (NCI)
Recurrent Ovarian Epithelial Cancer
12/14
12/15
NCT04774627: Pancytopenia Related to PARP Inhibitors (PancytoRIB)

Completed
N/A
200
Europe
PARP inhibitor, olaparib, rucaparib, niraparib, talazoparib, veliparib, pamiparib
University Hospital, Caen
Cancer
02/21
03/21
ArteRIB, NCT04774406: Arterial Hypertension Related to PARP Inhibitors

Completed
N/A
2336
Europe
olaparib, rucaparib, niraparib, talazoparib, veliparib, pamiparib, fluzoparib
University Hospital, Caen
Cancer
05/21
09/22
NCT02985658: Expanded Access With ABT-888 (Veliparib) to Treat Metastatic Breast Cancer

No Longer Available
N/A
US
Veliparib, ABT-888, Cisplatin, Platinol-AQ, Platinol, Vinorelbine, Navelbine
University of Washington, AbbVie
Metastatic Breast Cancer With BRCA 1 or BRCA 2 Genetic Mutation, Triple-Negative Breast Cancer
 
 
NCT03123211: Expanded Access to Veliparib

No Longer Available
N/A
NA
Veliparib, ABT-888
AbbVie
Solid Tumors With Documented BRCA, BARD, or PALB or Other Acceptable DNA Mutations or Anomalies That Are Scientifically Sound, Triple Negative Breast Cancer (TNBC), High Grade Serous Ovarian Cancer, Patients Requiring Veliparib Suspension Formulation
 
 
NCT02158507: Pilot Study of Veliparib (ABT-888) and Lapatinib (Tykerb) in Patients With Metastatic, Triple Negative Breast Cancer

Completed
N/A
23
US
Combination of Veliparib + Lapatinib, Veliparib (ABT-888), Lapatinib (Tykerb)
University of Alabama at Birmingham, Breast Cancer Research Foundation of Alabama, GlaxoSmithKline, AbbVie
Metastatic Triple Negative Breast Cancer
07/21
07/21

Download Options